Local Infusion, the leading tech enabled infusion provider, announced it has closed on a $10 million Series A funding round led by Blisce with participation from Meridian Street Capital and existing investors.

Local Infusion delivers comprehensive value-based care and infusion therapy to patients with chronic autoimmune diseases on specialty medications.